The elderly obese patients with long-standing and poorly controlled type 2 diabetes treated with high doses of insulin are at high risk of cancer development and they should be rigorously assessed towards malignancies, particularly breast cancer in women and colorectal cancer in men. The gene discussed is INS; the disease is breast carcinoma.